| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/07/2009 | EP2010176A2 Use of opioid antagonists to attenuate endothelial cell proliferation and migration |
| 01/07/2009 | EP2010170A2 Use of biarylcarboxamides in the treatment of hedgehog pathway-related disorders |
| 01/07/2009 | EP2010167A2 Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis |
| 01/07/2009 | EP2010152A1 Magnetic nanoparticles compositions and uses thereof |
| 01/07/2009 | EP1771443B1 Quinoline thiazolinones with cdk-1 antiproliferative activity |
| 01/07/2009 | EP1743651B1 Vaccine compositions which are obtained from streptomyces |
| 01/07/2009 | EP1680405B1 Bengamide derivatives and use thereof for the treatment of cancer |
| 01/07/2009 | EP1678163B1 Novel imidazole derivatives and their use as pharmaceutical agents |
| 01/07/2009 | EP1594885B1 Medicament for inhibiting tumour growth |
| 01/07/2009 | EP1581790B1 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 01/07/2009 | EP1560854B1 Taxanes covalently bound to hyaluronic acid or hyaluronic acid derivatives |
| 01/07/2009 | EP1551868B1 Factor involved in metastasis and uses thereof |
| 01/07/2009 | EP1542691B1 Composition for the treatment of nasopharyngeal carcinoma and use thereof |
| 01/07/2009 | EP1536827B1 Use of protein kinase n beta |
| 01/07/2009 | EP1511771B1 Anti-aurora-a monoclonal antibody, method for obtaining same, and uses thereof for diagnosing and treating cancers |
| 01/07/2009 | EP1474434B1 The eaat2 promoter and uses thereof |
| 01/07/2009 | EP1455840B1 Treatment of human soft tissue sarcoma with adenoviral vector expressing tnf-alpha |
| 01/07/2009 | EP1431285B1 Reverse hydroxamic acid derivatives |
| 01/07/2009 | EP1406641B1 Krill extracts for prevention and/or treatment of cardiovascular diseases |
| 01/07/2009 | EP1392662B1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
| 01/07/2009 | EP1223973B1 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 01/07/2009 | EP1218361B1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 01/07/2009 | EP1200590B1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 01/07/2009 | EP1028745B1 Low-dose interferon immunotherapy |
| 01/07/2009 | EP0662827B2 Diagnostic methods and pharmaceutical compositions based on notch proteins and nucleic acids |
| 01/07/2009 | CN101341171A Therapeutic agent |
| 01/07/2009 | CN101341151A Diazepinones |
| 01/07/2009 | CN101341145A Isoquinoline aminopyrazole derivatives, their manufacture and use as pharmaceutical agents for the treatment of cancer |
| 01/07/2009 | CN101341133A Quinazoline derivatives, process for their preparation and their use as anti-cancer agents |
| 01/07/2009 | CN101341132A Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer |
| 01/07/2009 | CN101340947A Combination of an iap-inhibitor and a taxane7 |
| 01/07/2009 | CN101340934A Immuno-RNA-constructs |
| 01/07/2009 | CN101340914A Reduction of side effects from aromatase inhibitors used for treating breast cancer |
| 01/07/2009 | CN101340913A Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
| 01/07/2009 | CN101340910A Treatment of drug-resistant tumors |
| 01/07/2009 | CN101340909A Method of inhibiting flt3 kinase |
| 01/07/2009 | CN101338321A Method for constructing and screening miRNAs expression vector of stomach cancer target FUT3 gene and uses thereof |
| 01/07/2009 | CN101338306A Method for treating cell proliferation hyperthyroidism based on anti-SURVIVIN ribozyme |
| 01/07/2009 | CN101338303A Adenovirus marked by radionuclide |
| 01/07/2009 | CN101338302A Recombination herpes simplex virus for tumor gene therapy |
| 01/07/2009 | CN101338296A Construction of attenuation salmonella bacterin with Vp3 and TRAIL co-expression plasmid |
| 01/07/2009 | CN101337992A Fusion protein of urokinase type plasminogen activator a chain and melittin and preparation thereof |
| 01/07/2009 | CN101337980A Ruthenium complexes for restraining DNA from topologizing isomerase , preparation method and application thereof |
| 01/07/2009 | CN101337972A Process for extracting vincaleuucoblastine from vinca |
| 01/07/2009 | CN101337957A Scutellarin derivates, preparation method and application thereof |
| 01/07/2009 | CN101337933A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337932A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337931A Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 01/07/2009 | CN101337928A Quinoline compounds, synthesizing method, applications in synthesis of alkaloid of camptothecins |
| 01/07/2009 | CN101337871A Indandione compound |
| 01/07/2009 | CN101337080A Radionuclide particle implantation medicine for cancer, use and preparation method thereof |
| 01/07/2009 | CN101337076A Functional dendritic polymer gene vector system of targeted malignant cerebroma |
| 01/07/2009 | CN101337065A Use of MG132 in preparing medicine for synergistic inductive differentiation therapy of leukaemia |
| 01/07/2009 | CN101337001A Solanum xanthocarpum extract, preparation method and use thereof |
| 01/07/2009 | CN101337000A Solanum nigrum extract, preparation method and use thereof |
| 01/07/2009 | CN101336983A Oldenlandia and quality control method of preparation containing oldenlandia |
| 01/07/2009 | CN101336973A Analgesic and anticancer traditional Chinese medicine preparation and preparation method thereof |
| 01/07/2009 | CN101336942A Preparation method of anticancer traditional Chinese medicine preparation-oleum fructus bruceae liquid-filled hard capsules |
| 01/07/2009 | CN101336941A Preparation methods of liverwort volatile oil, formulation thereof and use thereof in preparing anticancer medicine |
| 01/07/2009 | CN101336928A Use of saponins compound echinoside A in sea pumpkin in preparing tumor topoisomerase ó inhibitor |
| 01/07/2009 | CN101336926A Anticancer composition loaded with bortezomib and alkyl agent |
| 01/07/2009 | CN101336925A Use of PS-341 in preparing medicine for synergistic inductive differentiation therapy of leukaemia |
| 01/07/2009 | CN101336924A New use of cardiac glycoside in calotropis gigantea for anti-tumour |
| 01/07/2009 | CN101336918A Use of annonaceous acetogenins in preparing medicine for treating lung cancer or breast cancer |
| 01/07/2009 | CN101336917A Use of annonaceous acetogenins in preparing medicine for treating lung cancer or breast cancer |
| 01/07/2009 | CN101336916A Use of tea polyphenol |
| 01/07/2009 | CN101336915A Medicine combination with antitumor activity |
| 01/07/2009 | CN101336911A Compound sustained-released injection containing marimastat as neovascularization inhibitor |
| 01/07/2009 | CN101336909A Application of butein in preparing the medicine for preventing the blood vessel from regenerating |
| 01/07/2009 | CN101336902A Liposomes sodium morrhuate |
| 01/07/2009 | CN101336900A Anticancer sustained-released injection containing taxane |
| 01/07/2009 | CN101336899A Anticancer sustained-released injection containing taxane |
| 01/07/2009 | CN101336898A Anticancer sustained-released formulation loaded with platinum compound and synergist thereof |
| 01/07/2009 | CN101336894A Anticancer composition containing platinum compound and bortezomib |
| 01/07/2009 | CN101336893A Sustained-released injection containing bortezomib and topology enzyme inhibitor |
| 01/07/2009 | CN101336892A Gel injection of sustained-released topology enzyme inhibitor and preparation method thereof |
| 01/07/2009 | CN101336891A Anticancer sustained-released gel injection and preparation method thereof |
| 01/07/2009 | CN101336890A Anticancer sustained-release gel injection |
| 01/07/2009 | CN101336889A Anticancer sustained-released formulation loaded with blood vessel inhibitor and synergist thereof |
| 01/07/2009 | CN101336719A Nutrient powder capable of expelling toxin and preventing cancer |
| 01/07/2009 | CN100448994C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof |
| 01/07/2009 | CN100448985C Educated NKT cells and their uses in the treatment of immune-related disorder |
| 01/07/2009 | CN100448892C Antitumour vascular endothelial growth factor receptor VEGF-R antigen and its coding gene and application |
| 01/07/2009 | CN100448891C Peptides and related molecules that bind to TALL-1 |
| 01/07/2009 | CN100448889C Cytotoxic depsipeptides |
| 01/07/2009 | CN100448886C Derivative of protopanoxatriol, prepn. method and application thereof |
| 01/07/2009 | CN100448880C 2'oxo-voruscharin and derivatives thereof |
| 01/07/2009 | CN100448875C Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 01/07/2009 | CN100448874C N-aroyl cyclic amines |
| 01/07/2009 | CN100448870C 2-aminoquinoline derivative |
| 01/07/2009 | CN100448868C Tri-substituted heteroaryls and methods of making and using the same |
| 01/07/2009 | CN100448845C Natural and synthetic isothiocyanate kind compound and its application in treating and preventing cancer |
| 01/07/2009 | CN100448844C Inhibitors of histone deacetylase |
| 01/07/2009 | CN100448487C Method of treating estrogen receptor positive carcinoma |
| 01/07/2009 | CN100448486C Use of P2Y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 01/07/2009 | CN100448479C Application of compound PSI in preparation of medicine for treating leucocythemia |
| 01/07/2009 | CN100448466C Medicine for preventing and auxiliary treating cancer |
| 01/07/2009 | CN100448454C Cancer treatment composition and method using natural plant essential oils |
| 01/07/2009 | CN100448445C Application of kuianchun family compound in anti-tumor drug preparing process |